Diphenyl-tetrazol-propanamide Derivatives Act as Dual-Specific Antagonists of Platelet CLEC-2 and Glycoprotein VI
Thrombosis and Haemostasis · 01.03.2024 · 124 (03) · 203-222
DOI: 10.1055/a-2211-5202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.03.2024. Verfasst von Nobuo Watanabe und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan. Hauptthemen laut MEDLINE: Venous Thromboembolism, Biphenyl Compounds. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: AMED, Grant-in-aid.
Abstract (Originalsprache)
Background
Platelet C-type lectin-like receptor 2 (CLEC-2) induces platelet activation and aggregation after clustering by its ligand podoplanin (PDPN). PDPN, which is not normally expressed in cells in contact with blood flow, is induced in inflammatory immune cells and some malignant tumor cells, thereby increasing the risk of venous thromboembolism (VTE) and tumor metastasis. Therefore, small-molecule compounds that can interfere with the PDPN–CLEC-2 axis have the potential to become selective antiplatelet agents. Methods and Results Using molecular docking analysis of CLEC-2 and a PDPN–CLEC-2 binding-inhibition assay, we identified a group of diphenyl-tetrazol-propanamide derivatives as novel CLEC-2 inhibitors. A total of 12 hit compounds also inhibited PDPN-induced platelet aggregation in humans and mice. Unexpectedly, these compounds also fit the collagen-binding pocket of the glycoprotein VI molecule, thereby inhibiting collagen interaction. These compounds also inhibited collagen-induced platelet aggregation, and one compound ameliorated collagen-induced thrombocytopenia in mice. For clinical use, these compounds will require a degree of chemical modification to decrease albumin binding.
Conclusion
Nonetheless, as dual activation of platelets by collagen and PDPN-positive cells is expected to occur after the rupture of atherosclerotic plaques, these dual antagonists could represent a promising pharmacophore, particularly for arterial thrombosis, in addition to VTE and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
- Institute of Advanced Biosciences, Tokai University, Hiratsuka, Kanagawa, Japan.
- Support Center for Medical Research and Education, Tokai University, Isehara, Kanagawa, Japan.
- Department of Physiology, Tokai University School of Medicine, Shimokasuya, Isehara, Kanagawa, Japan.
- Department of Neurology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
- Department of Laboratory Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
ORCID-Profile: Nobuo Watanabe, Sadaki Inokuchi
Förderung
- AMED
- Grant-in-aid
Zitieren
APA
Watanabe, N., Shinozaki, Y., Ogiwara, S., Miyagasako, R., Sasaki, A., Kato, J., Suzuki, Y., Fukunishi, N., Okada, Y., Saito, T., Iida, Y., Higashiseto, M., Masuda, H., Nagata, E., Gotoh, K., Amino, M., Tsuji, T., Morita, S., Nakagawa, Y., …, & Inokuchi, S. (2024). Diphenyl-tetrazol-propanamide Derivatives Act as Dual-Specific Antagonists of Platelet CLEC-2 and Glycoprotein VI. Thrombosis and Haemostasis, 124(03), 203-222. https://doi.org/10.1055/a-2211-5202
Vancouver
Watanabe N, Shinozaki Y, Ogiwara S, Miyagasako R, Sasaki A, Kato J, et al. Diphenyl-tetrazol-propanamide Derivatives Act as Dual-Specific Antagonists of Platelet CLEC-2 and Glycoprotein VI. Thrombosis and Haemostasis. 2024;124(03):203-222. doi:10.1055/a-2211-5202
BibTeX
@article{Watanabe2024,
author = {Watanabe, Nobuo and Shinozaki, Yoshiko and Ogiwara, Sanae and Miyagasako, Riko and Sasaki, Ayumi and Kato, Junko and Suzuki, Yusuke and Fukunishi, Natsuko and Okada, Yoshinori and Saito, Takeshi and Iida, Yumi and Higashiseto, Misaki and Masuda, Haruchika and Nagata, Eiichiro and Gotoh, Kazuhito and Amino, Mari and Tsuji, Tomoatsu and Morita, Seiji and Nakagawa, Yoshihide and Hirayama, Noriaki and Inokuchi, Sadaki},
title = {Diphenyl-tetrazol-propanamide Derivatives Act as Dual-Specific Antagonists of Platelet CLEC-2 and Glycoprotein VI},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {03},
pages = {203--222},
doi = {10.1055/a-2211-5202}
}
EUVIMED